Healthcare (SH:603313) Mei Ri Jing Ji Xin Wen·2025-12-01 09:58Core Viewpoint - The recent share buyback and continuous increase in shareholding by the controlling shareholder of Dream Lily indicate strong confidence in the company's future performance, contributing to a significant rise in stock price this year. Group 1: Shareholding Increase - The controlling shareholder, Ni Zhanggen, and his concerted action party have recently increased their holdings in Dream Lily, with a total increase of 815,418 shares, accounting for 1.43% of the total share capital, and a cumulative investment of 67.24 million yuan [6][9]. - The latest share purchases occurred on November 26 and 27, 2025, where Dream Kang Company acquired 52,580 shares and 113,890 shares, respectively, for a total of approximately 14.99 million yuan [3][4]. - Since 2017, Ni Zhanggen has conducted multiple share buybacks, with a total investment exceeding 300 million yuan [8]. Group 2: Financial Performance - In the first three quarters of 2025, Dream Lily achieved a revenue of 6.756 billion yuan, a year-on-year increase of 10.29%, and a net profit of 161 million yuan, up 205.18% [9]. - The significant growth in online business revenue, particularly in overseas markets, has been a key driver of this performance, with overseas online revenue reaching 999.1 million yuan, a 68.28% increase year-on-year [9]. - The company completed a share buyback plan in September 2025, repurchasing 19.406 million shares, which is 3.40% of the total share capital, at an average price of 8.588 yuan per share [9]. Group 3: Stock Price Movement - Dream Lily's stock price has seen a maximum increase of over 50% this year, with a peak price of 10.48 yuan on October 22, 2025, compared to a closing price of 6.70 yuan at the end of 2024 [7]. - As of December 1, 2025, the stock closed at 9.26 yuan, maintaining a year-to-date increase of 38.21% [7].